JCO Precision Oncology
@JCOPO_ASCO
Original research, reports, opinions, and reviews advancing the science and practice of #precisiononcology. Part of @JCO_ASCO family of journals.
.@HyunAeJung62662 et al's pilot study introduces a deep-learning model that uses multimodal data from routine clinical practice to predict relapses in early-stage #NSCLC. Read the full article. brnw.ch/21wUp9m #LCSM

Combination Therapy With Olaparib Plus Lenvatinib in a Patient With BRCA2-Mutated, Radioiodine-Refractory, Metastatic Papillary Thyroid Cancer: A Case Report | @JCOPO_ASCO ascopubs.org/doi/10.1200/PO…
Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study @JCOPO_ASCO ascopubs.org/doi/10.1200/JC…
Cancer Testis Antigen Expression Correlates With Immune Activation and Survival in Small Bowel Neuroendocrine Tumors. Read the full article. brnw.ch/21wUkDr
Prognostic Role of MTAP Loss in Cholangiocarcinoma: brnw.ch/21wUjbD Authored by @alm_o et al.
Clinical Significance of TERT Promoter Mutations in #Neuroblastoma: brnw.ch/21wUiJz #pedcsm
Consistency and Heterogeneity of Microsatellite Instability (MSI) Status in Paired Biopsy and Surgical Specimens of #ColorectalCancer: A Necessity for MSI Reassessment After Treatment? Read the full article. brnw.ch/21wUfPa
LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair Genes. Read the full article. brnw.ch/21wUfrb
Germline POT1 Variants in a Pan-Cancer Cohort. Read the full article. brnw.ch/21wUdRp
Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell Therapy | @JCOPO_ASCO ascopubs.org/doi/10.1200/PO…
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma. brnw.ch/21wUdvQ #sarcoma
Transcriptomic Predictors of Survival for Palbociclib 1 Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor–Resistant #BreastCancer From the GEICAM/ 2013-02 PEARL Trial. Read the full article. brnw.ch/21wUc7t
Real-World Clinical Utility of Tumor Next-Generation Sequencing in Adolescent and Young Adult Patients With #Sarcoma. brnw.ch/21wUbMu #ayacsm
Prostate-Related Germline Variant Frequencies Detected in a Cohort of Men With Metastatic #ProstateCancer in Northern India. Read the full article. brnw.ch/21wUay2
Risk Assessment With Ultra-Low-Pass Whole-Genome Sequencing of Cell-Free DNA for #LargeBCellLymphoma. Read the full article. brnw.ch/21wUadq
Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in #OvarianCancer: brnw.ch/21wU9RY #gynonc
Quantifying the Value of Molecular Tumor Board: Discordance Rec Rate & Drug Cost Avoidance [Oct 20, 2022] @mkwalters305 et al. @JCOPO_ASCO ascopubs.org/doi/abs/10.120… #PrecisionMedicine #hpeonc Table 2
Big news! #JCOPO is excited to announce @KeyanSalari has joined us as an Associate Editor. Welcome aboard, Dr. Salari!

Fidelity of Next-Generation Sequencing to Predict Human Epidermal Growth Factor 2 Overexpression Across Solid Tumors. Co-authored by @MyaPrecisionG. Read full article. brnw.ch/21wU4vg
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma. Read full article. brnw.ch/21wU31m